Error! You must javascript enabled to use this form. Please enable Javascript in your browser. Biosimilars The Future of Biotech Over-expensive drugs are encouraging the pharma companies to look for biosimilar versions in the US biotechnology sector, says RNCOS. View full press release Your Name: Your Email: Subject: Question: We respects your privacy, the information you entered above will not be used to send unsolicited email, and will not be rented or sold to a 3rd party. Your contact information will be shared with the recipient of this message - Privacy Policy Send